Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000319541 | SCV000373371 | likely benign | Autosomal dominant cerebellar ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000518507 | SCV000615484 | benign | not specified | 2017-07-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001518725 | SCV001727477 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001518725 | SCV001950905 | benign | not provided | 2021-04-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001518725 | SCV005216667 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003983005 | SCV004796109 | benign | SPTBN2-related disorder | 2019-07-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |